This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Remifentanil 1 mg vials. The contract has a ceiling value of $1,755.60 and a period of performance through October 31, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 1 mg vials of the pharmaceutical drug remifentanil, with a firm fixed price ceiling value of $3,072.30 and a completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of remifentanil 1 mg vials, a specialty medication used for pain management. The contract has a ceiling value of $8,173.26 and runs through February 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REMIFENTANIL 1 MG VIALS. The contract has a ceiling value of $3,667.30 and is a firm-fixed price contract with a completion date of June 24, 2025. The contract is not set-aside and was awarded on June 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,852.40, is for the delivery of REMIFENTANIL 2 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,699.97, is for the delivery of 2 mg vials of the drug Remifentanil. The contract has a period of performance through May 24, 2024 and utilizes a Firm Fixed Price pricing type. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4563682087 REMIFENTANIL 1 MG VIALS. The contract has a completion date of February 16, 2024 and a potential value of $1,929.60. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on May 12, 2025. The contract has a ceiling value of $1,075.15 and is for the delivery of REMIFENTANIL 2 MG VIALS. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,266.80. The contract is for the supply of REMIFENTANIL 1 MG VIALS, a pharmaceutical product used for anesthesia and pain management. The award has a firm-fixed price and is not associated with any set-aside designations. AmerisourceBergen Drug Corp, through its Corporate Office Division, has a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 1 MG VIALS, a prescription medication. The contract has a firm fixed price, a ceiling value of $9,989.54, and an ultimate completion date of June 26, 2025. This delivery order is not set aside for any specific business type. Amerisourcebergen Drug Corp holds...